NorthRock Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,135
Closed -$311K 297
2019
Q3
$311K Sell
3,135
-5,300
-63% -$526K 0.04% 163
2019
Q2
$780K Sell
8,435
-184
-2% -$17K 0.22% 24
2019
Q1
$814K Sell
8,619
-373
-4% -$35.2K 0.21% 27
2018
Q4
$579K Buy
8,992
+557
+7% +$35.9K 0.17% 40
2018
Q3
$755K Buy
8,435
+144
+2% +$12.9K 0.22% 23
2018
Q2
$660K Sell
8,291
-626
-7% -$49.8K 0.23% 21
2018
Q1
$798K Buy
8,917
+507
+6% +$45.4K 0.26% 18
2017
Q4
$878K Sell
8,410
-200
-2% -$20.9K 0.28% 17
2017
Q3
$1.25M Hold
8,610
0.48% 14
2017
Q2
$1.12M Buy
8,610
+525
+6% +$68.2K 0.47% 13
2017
Q1
$1.01M Sell
8,085
-5,328
-40% -$664K 0.43% 17
2016
Q4
$1.55M Sell
13,413
-46
-0.3% -$5.32K 0.55% 19
2016
Q3
$1.41M Buy
13,459
+7,270
+117% +$760K 0.6% 12
2016
Q2
$571K Buy
6,189
+4,177
+208% +$385K 0.26% 23
2016
Q1
$202K Sell
2,012
-6,381
-76% -$641K 0.1% 44
2015
Q4
$994K Sell
8,393
-1,400
-14% -$166K 0.58% 14
2015
Q3
$1.08M Sell
9,793
-4,001
-29% -$439K 0.68% 14
2015
Q2
$1.6M Buy
13,794
+156
+1% +$18K 0.74% 14
2015
Q1
$1.57M Buy
13,638
+351
+3% +$40.5K 0.93% 10
2014
Q4
$1.49M Buy
+13,287
New +$1.49M 0.91% 10